BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25051374)

  • 1. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells.
    Meng G; Xia M; Wang D; Chen A; Wang Y; Wang H; Yu D; Wei J
    Oncotarget; 2014 Aug; 5(15):6365-74. PubMed ID: 25051374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
    Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
    BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition suppresses Newcastle disease virus-induced cell death by inhibiting viral replication in human breast cancer cells.
    Rozilah MI; Yusoff K; Chia SL; Ismail S
    Virology; 2024 Feb; 590():109957. PubMed ID: 38100982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient activation of the PI3K/Akt pathway promotes Newcastle disease virus replication and enhances anti-apoptotic signaling responses.
    Kang Y; Yuan R; Zhao X; Xiang B; Gao S; Gao P; Dai X; Feng M; Li Y; Xie P; Li Y; Gao X; Ren T
    Oncotarget; 2017 Apr; 8(14):23551-23563. PubMed ID: 28423596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
    Mansour M; Palese P; Zamarin D
    J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.
    Xia M; Meng G; Jiang A; Chen A; Dahlhaus M; Gonzalez P; Beltinger C; Wei J
    Oncotarget; 2014 Jun; 5(11):3907-18. PubMed ID: 25004098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways.
    Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A
    Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
    Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
    Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240.
    Ghrici M; El Zowalaty M; Omar AR; Ideris A
    Oncol Rep; 2013 Sep; 30(3):1035-44. PubMed ID: 23807159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death.
    Elankumaran S; Rockemann D; Samal SK
    J Virol; 2006 Aug; 80(15):7522-34. PubMed ID: 16840332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.
    Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X
    Virol J; 2014 May; 11():84. PubMed ID: 24885546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
    Yurchenko KS; Zhou P; Kovner AV; Zavjalov EL; Shestopalova LV; Shestopalov AM
    PLoS One; 2018; 13(4):e0195425. PubMed ID: 29621357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.
    Kumar U; Kumar S
    Cancer Gene Ther; 2015 Aug; 22(8):402-9. PubMed ID: 26251032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy benefits the replication of Newcastle disease virus in chicken cells and tissues.
    Sun Y; Yu S; Ding N; Meng C; Meng S; Zhang S; Zhan Y; Qiu X; Tan L; Chen H; Song C; Ding C
    J Virol; 2014 Jan; 88(1):525-37. PubMed ID: 24173218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
    Kalyanasundram J; Hamid A; Yusoff K; Chia SL
    Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo.
    Meng S; Zhou Z; Chen F; Kong X; Liu H; Jiang K; Liu W; Hu M; Zhang X; Ding C; Wu Y
    Cancer Lett; 2012 Apr; 317(1):56-64. PubMed ID: 22095029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model.
    He J; An Y; Qi J; Cui L; Yang K; Liu M; Qu B; Yan S; Yin J; Jing X; Dong H; Yu Q; Li D; Wu Y
    J Med Virol; 2021 Jun; 93(6):3890-3898. PubMed ID: 32779745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.